Employee Benefits Managers Key To Conceptus’ Device Coverage Strategy
This article was originally published in The Gray Sheet
Executive Summary
A Conceptus-funded survey suggesting that insurers are less likely to cover newer contraceptive options underlies the firm's push to educate benefits managers about its Essure device
You may also be interested in...
APC Panel Meeting Will Allow Manufacturers To Address OPPS Payment Cuts
CMS does not intend to adjust median costs for ambulatory payment classification (APC) groups in the 2004 hospital outpatient prospective payment system update, despite 54 device-related categories facing payment cuts in excess of 10%
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.